Evidence map›Paper›PMID 18159898›Full record

ReviewAdvances in dermatology2007

Growth factors and oncogenes as targets in melanoma: lost in translation?

Lawrence Kwong, Lynda Chin, Stephan N Wagner

Abstract readReview
In one paragraph

Review in Advances in dermatology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
  2. Article
  3. RSK1 activation promotes invasion in nodular melanoma.The American journal of pathology · 2015
    Article
  4. Histology-specific microRNA alterations in melanoma.The Journal of investigative dermatology · 2012
    Article
  5. Review
  6. Article
  7. Article
  8. Genetics and genomics of melanoma.Expert review of dermatology · 2009
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lawrence KwongDepartment of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA.
Lynda Chin
Stephan N Wagner

Funding

Targeting Raf in Melanoma: Mechanisms for Effect & Resistance & Opportunities forP50CA093683 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI GOLUB, TODD R. · 2001 to 2012
$25.8M
Transcriptional mechanisms and melanomaP01CA163222 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Kai W Wucherpfennig · 2013 to 2026
$25.3M
MOUSE MODEL OF MALIGNANT MELANOMAU01CA084313 · NCI · DANA-FARBER CANCER INSTITUTE · PI DEPINHO, RONALD ANTHONY · 1999 to 2008
$7.4M
The genetic Basis of Melanoma MetastasisR01CA093947 · NCI · DANA-FARBER CANCER INSTITUTE · PI CHIN, LYNDA · 2002 to 2011
$3.6M
NCI NIH HHS P01 CA163222NCI NIH HHS P50 CA093683NCI NIH HHS R01 CA093947NCI NIH HHS R01 CA93947NCI NIH HHS U01 CA084313
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GenomeAdaptor Proteins, Signal TransducingDisease ProgressionGenetic TechniquesHumansIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsMAP Kinase Signaling SystemMelanomaMicrophthalmia-Associated Transcription FactorNeoplasm MetastasisOncogenesPhosphoproteinsReceptor Protein-Tyrosine KinasesSkin NeoplasmsAdaptor Proteins, Signal TransducingIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsMicrophthalmia-Associated Transcription FactorNEDD9 protein, humanPhosphoproteinsReceptor Protein-Tyrosine Kinases

Identifiers

PMID18159898
PMCPMC2603613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.